These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 35686004)

  • 1. Green decoration of graphene oxide Nano sheets with gelatin and gum Arabic for targeted delivery of doxorubicin.
    Hasanin M; Taha NF; Abdou AR; Emara LH
    Biotechnol Rep (Amst); 2022 Jun; 34():e00722. PubMed ID: 35686004
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Co-delivery of cisplatin and doxorubicin by carboxylic acid functionalized poly (hydroxyethyl methacrylate)/reduced graphene nanocomposite for combination chemotherapy of breast cancer cells.
    Astani S; Salehi R; Massoumi B; Massoudi A
    J Biomater Sci Polym Ed; 2021 Apr; 32(5):657-677. PubMed ID: 33347395
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Novel pH-sensitive Nanocomposite Based on Graphene Oxide for Improving Doxorubicin Release.
    Kachousangi MJ; Shadboorestan A; Shamsian A; Amini M; Atyabi F; Ghahremani MH
    Curr Drug Deliv; 2024; 21(1):140-153. PubMed ID: 37056059
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cu (II)-porphyrin metal-organic framework/graphene oxide: synthesis, characterization, and application as a pH-responsive drug carrier for breast cancer treatment.
    Gharehdaghi Z; Rahimi R; Naghib SM; Molaabasi F
    J Biol Inorg Chem; 2021 Sep; 26(6):689-704. PubMed ID: 34420089
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preparation and antitumor study of intelligent injectable hydrogel: Carboxymethyl chitosan-aldehyde gum Arabic composite graphene oxide hydrogel.
    Li L; Xiang F; Wang F; Liu Y
    Int J Biol Macromol; 2024 Feb; 259(Pt 2):129429. PubMed ID: 38232874
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preparation of pH-sensitive chitosan/polyvinylpyrrolidone/α-Fe
    Gerami SE; Pourmadadi M; Fatoorehchi H; Yazdian F; Rashedi H; Nigjeh MN
    Int J Biol Macromol; 2021 Mar; 173():409-420. PubMed ID: 33454326
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development and Characterization of Biocompatible Mannose Functionalized Mesospheres: an Effective Chemotherapeutic Approach for Lung Cancer Targeting.
    Gautam L; Sharma R; Shrivastava P; Vyas S; Vyas SP
    AAPS PharmSciTech; 2020 Jul; 21(5):190. PubMed ID: 32661573
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PEGylated nano-graphene oxide as a nanocarrier for delivering mixed anticancer drugs to improve anticancer activity.
    Pei X; Zhu Z; Gan Z; Chen J; Zhang X; Cheng X; Wan Q; Wang J
    Sci Rep; 2020 Feb; 10(1):2717. PubMed ID: 32066812
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Green one-pot synthesis of carboxymethylcellulose/Zn-based metal-organic framework/graphene oxide bio-nanocomposite as a nanocarrier for drug delivery system.
    Javanbakht S; Pooresmaeil M; Namazi H
    Carbohydr Polym; 2019 Mar; 208():294-301. PubMed ID: 30658803
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Normalization of doxorubicin release from graphene oxide: New approach for optimization of effective parameters on drug loading.
    Hashemi M; Yadegari A; Yazdanpanah G; Omidi M; Jabbehdari S; Haghiralsadat F; Yazdian F; Tayebi L
    Biotechnol Appl Biochem; 2017 May; 64(3):433-442. PubMed ID: 26878983
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of A Novel System Based on Green Magnetic / Graphene Oxide / Chitosan /Allium Sativum / Quercus / Nanocomposite for Targeted Release of Doxorubicin Anti-Cancer Drug.
    Arjmand O; Ardjmand M; Amani AM; Eikani MH
    Anticancer Agents Med Chem; 2020; 20(9):1094-1104. PubMed ID: 32053085
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Heparin modified graphene oxide for pH-sensitive sustained release of doxorubicin hydrochloride.
    Zhang B; Yang X; Wang Y; Zhai G
    Mater Sci Eng C Mater Biol Appl; 2017 Jun; 75():198-206. PubMed ID: 28415455
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of a graphene oxide-poly lactide nanocomposite as a Smart Drug Delivery System.
    Ghamkhari A; Abbaspour-Ravasjani S; Talebi M; Hamishehkar H; Hamblin MR
    Int J Biol Macromol; 2021 Feb; 169():521-531. PubMed ID: 33340628
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fabrication of chitosan/poly(lactic acid)/graphene oxide/TiO
    Samadi S; Moradkhani M; Beheshti H; Irani M; Aliabadi M
    Int J Biol Macromol; 2018 Apr; 110():416-424. PubMed ID: 28801095
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Green fabricated reduced graphene oxide: evaluation of its application as nano-carrier for pH-sensitive drug delivery.
    Ma N; Zhang B; Liu J; Zhang P; Li Z; Luan Y
    Int J Pharm; 2015 Dec; 496(2):984-92. PubMed ID: 26541300
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Magnetic Graphene Oxide for Dual Targeted Delivery of Doxorubicin and Photothermal Therapy.
    Lu YJ; Lin PY; Huang PH; Kuo CY; Shalumon KT; Chen MY; Chen JP
    Nanomaterials (Basel); 2018 Mar; 8(4):. PubMed ID: 29584656
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Natural gelatin capped mesoporous silica nanoparticles for intracellular acid-triggered drug delivery.
    Zou Z; He D; He X; Wang K; Yang X; Qing Z; Zhou Q
    Langmuir; 2013 Oct; 29(41):12804-10. PubMed ID: 24073830
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Simple preparation of maltose-functionalized dendrimer/graphene quantum dots as a pH-sensitive biocompatible carrier for targeted delivery of doxorubicin.
    Karimi S; Namazi H
    Int J Biol Macromol; 2020 Aug; 156():648-659. PubMed ID: 32289413
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Magnetic and GRPR-targeted reduced graphene oxide/doxorubicin nanocomposite for dual-targeted chemo-photothermal cancer therapy.
    Dash BS; Lu YJ; Chen HA; Chuang CC; Chen JP
    Mater Sci Eng C Mater Biol Appl; 2021 Sep; 128():112311. PubMed ID: 34474862
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A porous reduced graphene oxide/chitosan-based nanocarrier as a delivery system of doxorubicin.
    Hazhir N; Chekin F; Raoof JB; Fathi S
    RSC Adv; 2019 Sep; 9(53):30729-30735. PubMed ID: 35529364
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.